Results 11 to 20 of about 485,993 (264)
Histopathological transformation to small-cell lung carcinoma in non-small cell lung carcinoma tumors [PDF]
Translational Lung Cancer Research, 2016 Lung cancer is the principal cause of cancer-related death worldwide. The use of targeted therapies, especially tyrosine kinase inhibitors (TKIs), in specific groups of patients has dramatically improved the prognosis of this disease, although inevitably some patients will develop resistance to these drugs during active treatment.
Rita, Dorantes-Heredia +2 more
openaire +2 more sources
Iris Metastasis in Small-Cell Lung Carcinoma [PDF]
Journal of Thoracic Oncology, 2007 Small-cell lung cancer (SCLC) is characterized by rapid growth and early metastasis. Despite its sensitivity to cytotoxic treatment, until now treatments have failed to control or cure this disease in most patients. Here, we describe a patient with SCLC in which symptoms caused by iris metastasis were the only sign of relapse after multimodality ...
Roenhorst, Anke W. J. +3 more
openaire +3 more sources
Cancer Management and Research, 2023 Zhisheng Liu,1,* Junling Zhang,2,* Yunjie Ge,3 Mengli Huang,2 Ye Wang1 1Department of General Surgery, Affiliated Qingdao Hiser Hospital of Qingdao University (Qingdao Hospital of Traditional Chinese Medicine), Qingdao, Shandong People’s Republic
Liu Z, Zhang J, Ge Y, Huang M, Wang Y
doaj
Neurotensin in human small cell lung carcinoma [PDF]
British Journal of Cancer, 1984 High levels of neurotensin-like immunoreactivity were found in human small cell lung carcinoma lines. No immunoreactivity was present in non-small cell carcinoma lines and only low amounts in postmortem human lung tissue. The immunoreactive material co-eluted with synthetic neurotensin on two different chromatographic systems.
M, Goedert +3 more
openaire +3 more sources
Cancer Management and Research, 2023 Diming Wang,1,* Wei Ye,2,* Dongmei Chen,1 Qingming Shi,1 Dongchun Ma3 1Department of Oncology, Anhui Chest Hospital, Hefei, 230022, People’s Republic of China; 2Department of Pathology, Anhui Chest Hospital, Hefei, 230022, People’s Republic of ...
Wang D, Ye W, Chen D, Shi Q, Ma D
doaj
Cytokeratin-negative small cell lung carcinoma
Rare Tumors, 2011 Cytokeratins (CK) are good markers of epithelial tumors, and most of carcinomas including small cell lung carcinoma (SCLC) expresses CK. Herein reported is a case of SCLC without CK expression.
Tadashi Terada
doaj +1 more source
Characteristics of Peripheral versus Central Lung Cancer Since 2000 [PDF]
Kosin Medical Journal, 2014 Objectives The aim of this study was to explore the changes of bronchoscopic features according to epidemiologic change of lung cancer. Methods We performed a retrospective review of the clinical characteristics of 1,139 lung cancer patient who underwent
So Young Ock +6 more
doaj +1 more source
the Immunohistochemical Study of Stathmin-1 as A Prognostic factor In Non-small cell lung carcinoma
مجلة كلية الطب, 2023 Background Stathmin1 (also known as metablastin) is a major microtubule-depolymerizing protein that involved in cell cycle progression and cell motility.
Nadhema Bahaa Hussein Wetwet +3 more
doaj +1 more source
Lung India, 2018 A subset of non-small cell lung carcinoma (NSCC) harbor active mutations of epidermal growth factor receptor (EGFR). In these, EGFR tyrosine kinase inhibitors (EGFR-TKIs) are recommended as the first-line treatment.
Monalisa Hui +3 more
doaj +1 more source
Tumor Biology, 2017 In this study, we evaluated the prognostic potential and functional regulation of human nature antisense, brain-derived neurotrophic factor antisense, in non–small cell lung cancer.
MingJing Shen +5 more
doaj +1 more source